NASDAQ:CYAN Cyanotech Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cyanotech Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.68 +0.07 (+2.68 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$2.46Now: $2.68▼$2.6850-Day Range$2.19MA: $2.52▼$3.1452-Week Range$1.82Now: $2.68▼$3.25Volume17,376 shsAverage Volume11,545 shsMarket Capitalization$16.16 millionP/E Ratio24.37Dividend YieldN/ABeta0.57 ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cyanotech. Previous Next 2.4 Community Rank Outperform VotesCyanotech has received 128 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCyanotech has received 141 “underperform” votes. (Add your “underperform” vote.)Community SentimentCyanotech has received 52.42% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cyanotech and other stocks. Vote “Outperform” if you believe CYAN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CYAN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCyanotech does not currently pay a dividend.Dividend GrowthCyanotech does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cyanotech insiders have bought more of their company's stock than they have sold. Specifically, they have bought $64,641.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 26.20% of the stock of Cyanotech is held by insiders.Percentage Held by InstitutionsOnly 11.30% of the stock of Cyanotech is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cyanotech is 24.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.91.Price to Earnings Ratio vs. SectorThe P/E ratio of Cyanotech is 24.37, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.04.Price to Book Value per Share RatioCyanotech has a P/B Ratio of 1.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.21 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CYAN Previous Symbol CUSIPN/A CIK768408 Webwww.cyanotech.com Phone808-326-1353Debt Debt-to-Equity Ratio0.57 Current Ratio2.16 Quick Ratio0.79Price-To-Earnings Trailing P/E Ratio24.37 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$31.90 million Price / Sales0.51 Cash Flow$0.40 per share Price / Cash Flow6.75 Book Value$2.67 per share Price / Book1.00Profitability EPS (Most Recent Fiscal Year)N/A Net Income$390,000.00 Net Margins2.11% Return on Equity4.20% Return on Assets2.04%Miscellaneous Employees118 Outstanding Shares6,031,000Market Cap$16.16 million Next Earnings Date11/10/2020 (Estimated) OptionableNot Optionable $2.68 +0.07 (+2.68 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CYAN News and Ratings via Email Sign-up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Cyanotech (NASDAQ:CYAN) Frequently Asked Questions How has Cyanotech's stock price been impacted by COVID-19 (Coronavirus)? Cyanotech's stock was trading at $1.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CYAN stock has increased by 34.7% and is now trading at $2.68. View which stocks have been most impacted by COVID-19. When is Cyanotech's next earnings date? Cyanotech is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Cyanotech. How were Cyanotech's earnings last quarter? Cyanotech Corp (NASDAQ:CYAN) announced its quarterly earnings results on Tuesday, August, 11th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company earned $7.35 million during the quarter. Cyanotech had a net margin of 2.11% and a return on equity of 4.20%. View Cyanotech's earnings history. Are investors shorting Cyanotech? Cyanotech saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 900 shares, an increase of 50.0% from the August 15th total of 600 shares. Based on an average daily volume of 13,400 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company's stock are sold short. View Cyanotech's Short Interest. Who are some of Cyanotech's key competitors? Some companies that are related to Cyanotech include Happiness Biotech Group (HAPP), Natural Alternatives International (NAII), Mannatech (MTEX), Sundial Growers (SNDL), True Drinks (TRUU), FitLife Brands (FTLF), GLG Life Tech (GLGLF), Tauriga Sciences (TAUG), Exactus (EXDI), Nutra Pharma (NPHC), Entia Biosciences (ERGO), Beleave (BE), Beleave (BE) and Rock Creek Pharmaceuticals (RCPIQ). View all competitors. What other stocks do shareholders of Cyanotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cyanotech investors own include Allena Pharmaceuticals (ALNA), Clarivate Analytics (CCC), Gilead Sciences (GILD), Madrigal Pharmaceuticals (MDGL), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX), Amarin (AMRN), BlackRock Resources and Commodities (BCX) and Bausch Health Companies (BHC). Who are Cyanotech's key executives? Cyanotech's management team includes the following people: Mr. Mawae R. Morton, Chief Exec. Officer (Age 52)Dr. Gerald R. Cysewski Ph.D., Co-Founder, Pres & Vice Chairman (Age 70)Mr. Brian Brett Orlopp, VP of Fin. & CFO and Sec.Mr. Glenn D. Jensen, VP of Manufacturing & Infrastructure (Age 61) What is Cyanotech's stock symbol? Cyanotech trades on the NASDAQ under the ticker symbol "CYAN." Who are Cyanotech's major shareholders? Cyanotech's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Heritage Investors Management Corp (0.22%). Company insiders that own Cyanotech stock include Jennifer M Johansen and Michael A / Davis. View institutional ownership trends for Cyanotech. Which major investors are buying Cyanotech stock? CYAN stock was bought by a variety of institutional investors in the last quarter, including Heritage Investors Management Corp. View insider buying and selling activity for Cyanotech. How do I buy shares of Cyanotech? Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cyanotech's stock price today? One share of CYAN stock can currently be purchased for approximately $2.68. How big of a company is Cyanotech? Cyanotech has a market capitalization of $16.16 million and generates $31.90 million in revenue each year. Cyanotech employs 118 workers across the globe. What is Cyanotech's official website? The official website for Cyanotech is www.cyanotech.com. How can I contact Cyanotech? Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected] This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
